Sep 08, 2026
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.35 to $7.00.
The split itself did not change the total investment value.
Cytosorbents Corporation (NASDAQ:CTSO) operates in the Medical specialties industry.
Cytosorbents Corporation company overviewCytosorbents Corporation's most recent stock split was on September 8, 2026. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
Cytosorbents Corporation (NASDAQ:CTSO) has split its stock 2 times: a 1-for-25 reverse split on December 5, 2014 and a 1-for-20 reverse split on September 8, 2026.
Cytosorbents Corporation has split its stock 2 times. This history records 2 reverse splits between December 5, 2014 and September 8, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Cytosorbents Corporation's 1-for-20 reverse split on September 8, 2026, every 20 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Cytosorbents Corporation has not announced a new split in our records. Its most recent split was on September 8, 2026, less than a year ago. Companies announce splits in advance, and any new NASDAQ:CTSO split will appear on this page.